Abstract:Background: Cervical cancer (CC) is the most common gynecological malignancy. Recently, an increasing number of studies have indicated that osteopontin (OPN) is a promising diagnostic and prognostic biomarker for CC. However, the biological role and detailed mechanism of OPN in CC remain unclear. Methods: The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) datasets and a clinical sample microarray were used in our study. To identify the clinicopathological characteristics of OPN in CC, we compared the expression of OPN between normal and CC tissue samples and analyzed the correlations between OPN expression and multiple clinicopathological features. To identify biological processes involving OPN, OPN-associated genes were screened with Pearson correlation analysis and applied in hallmark gene set enrichment analysis (GSEA). Additionally, leukocyte infiltration was evaluated based on OPN expression. Finally, OPN-related signaling pathways were identified by GSEA. Results: OPN expression was higher in CC samples than in normal tissue samples and positively correlated with age, FIGO stage, tumor size, lymphovascular invasion and an unfavorable prognosis. OPN-associated genes were mainly enriched in the immune response, and increased OPN expression was accompanied by increased M2 macrophage infiltration. Additionally, OPN was correlated with hypoxia, high glycolytic metabolism, apoptosis, angiogenesis, epithelial-mesenchymal transition and multiple signaling pathways (the p53 pathway, the PI3K/Akt pathway, IL6/STAT3 signaling, mTORC1 signaling and KRAS signaling). Conclusion: Our study showed that OPN is involved in immunological activities and multiple tumor processes, identifying it as a potential therapeutic target and useful prognostic factor in CC patients.

Human Osteopontin: Potential Clinical Applications In Cancer

Osteopontin in Bone Metabolism and Bone Diseases

The role of osteopontin in the progression of solid organ tumour

Osteopontin and its downstream carcinogenic molecules: regulatory mechanisms and prognostic value in cancer progression

Osteopontin: A Key Regulator of Tumor Progression and Immunomodulation

Osteopontin As Potential Biomarker and Therapeutic Target in Gastric and Liver Cancers.

Osteopontin As a Biomarker for Osteosarcoma Therapy and Prognosis

Osteopontin As a Multifaceted Driver of Bone Metastasis and Drug Resistance

Osteopontin and Lung Cancer

Correlation Between Osteopontin and Malignant Infiltration and Metastasis, a Brief Update

Biological and Clinicopathological Characteristics of OPN in Cervical Cancers

Osteopontin:tumor Metastasis-Associated Protein

OPN-a Splicing Variant Expression in Non-small Cell Lung Cancer and Its Effects on the Bone Metastatic Abilities of Lung Cancer Cells in Vitro.

Clinical and in Vitro Analysis of Osteopontin As a Prognostic Indicator and Unveil Its Potential Downstream Targets in Bladder Cancer

Overexpression of Osteopontin in Hepatocellular Carcinoma and Its Relationships with Metastasis, Invasion of Tumor Cells

Endocrine regulation and metabolic mechanisms of osteopontin in the development and progression of osteosarcoma, metastasis and prognosis

Research progress on the correlation between osteopontin and non-smalll cell lung cancer

The Role of Osteopontin in Tumor Progression Through Tumor-Associated Macrophages

Osteopontin is a Novel Prognostic Biomarker in Early-Stage Non-Small Cell Lung Cancer after Surgical Resection

Role of osteopontin in lung cancer evolution and heterogeneity.

Osteopontin as a Link between Inflammation and Cancer: The Thorax in the Spotlight